Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery

NCT00474773 · clinicaltrials.gov ↗

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Pain Management
Function
Minimally Invasive Total Knee Arthroplasty
Celecoxib

Interventions

DRUG: Celecoxib

Sponsor

St. Louis Joint Replacement Institute

Collaborators

[object Object]
[object Object]